Epsilon M&A Deal Report - Carechoice
Transaction Multiples for the Valuation of Private Companies

Private Group Led by InfraVia Capital Partners > Carechoice
Announced Date : 06 April 2017
Type : SBO (Secondary Buy Out) ,Exit
Deal Value : Yes
Acquirer : Private Group Led by InfraVia Capital Partners
Target Carechoice
Target Country Ireland
Sector of activity : Health, Pharmaceuticals & Biotechnology
> Carechoice currently operates six nursing homes across Ireland (in Dublin, Cork and Waterford), providing over 500 high quality of care beds for elderly (Source: ...

Transaction multiples available
EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
---|---|---|---|---|---|---|---|
Historic | |||||||
Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating *
Source: Epsilon Research / EMAT

Comparable Transactions
Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226
Example of comparable transactions on EMAT (same sub-sector):
Date | Acquirer | Target | Country | Multiples | See details |
---|---|---|---|---|---|
16/09/2014 | Nicox | Doliage | France | 0 | |
27/04/2017 | Private Group led by IK Investment Partners | Colisée Patrimoine Group | France | 0 |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database